Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA. Shares in the company gained almost 24% ...
Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results